Today, many hope artificial intelligence will be the key that unlocks the value of digitization. Perhaps it will, but the claim that better technology will necessarily improve healthcare is no longer credible. Having lived in both analog and digital worlds, who better than us Oregon Trail doctors to help ensure digital health technologies best serve our workforce, patients, and communities?
The only way to effectively scale care coordination to meet the needs of digital consumers is through technology, combined with empowered staff and transformed processes.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Equitable AI isn’t an aspiration; it’s an absolute necessity, particularly for the millions of older Americans who remain unseen within the current frameworks and miss out on algorithmic benefits such as risk profiles and early interventions for certain diseases.
A preview of ViVE 2024 offers a sneak peek at the agenda and how the Payer and Provider Connect meeting platform initiatives have been revamped to maximize the quantity and quality of meeting for healthcare executives.
The shift towards digital pathology has marked a significant advancement in breast cancer diagnosis. High-resolution digital imaging of slides provides pathologists with an unprecedentedly clear and expansive view of tissue samples for their analysis.
AI, health equity and merger and acquisition activity are among the trends to watch in 2024, according to a recent report from Deloitte.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
A recent Deloitte report found that improving health equity is a top-10 goal for 83% of life sciences and healthcare C-suite executives in 2024. The report also laid out factors that will likely influence health equity in 2024, including AI.
There are three key trends for the healthcare industry to follow in 2024, including the rise of AI, increasing cost pressures and M&A activity, according to West Monroe.
AI may transform health care across the board, but not by itself. It's a tool, and like any tool, it will work more effectively and more safely in trained hands. As the AI revolution continues to grow, we believe organizations should invest in that training now.
Providers who don't take advantage of AI will get "left behind," said Dr. Shantanu Gaur, founder and CEO of Allurion Technologies, during a panel discussion at INVEST Digital Health.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
At HLTH, Bessemer investors Sofia Guerra and Steve Kraus detailed four predictions about where they think the digital health world is headed in 2024. One of these was that "services-as-software" will emerge as a new category of healthcare AI. Another was that some healthcare technology vendors will have to rethink their distribution models and rely on indirect monetization strategies.
HLTH 2023 introduced a new program focused on technology trends for and perspectives from payers in a series of conversations around AI, health equity and healthcare innovation.
The revenue cycle management business is using AI tools to automate cumbersome tasks to help hospitals operate more efficiently. It's beginning to attract the attention of major healthcare organizations.
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
This new report sheds light on how the benefit consultants’ role has changed and details their perspective on the shifting employer healthcare landscape.